First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin’s lymphoma

被引：0
|
作者：
D Ghez
C Fortpied
N Mounier
P Carde
A Perrot
H Khaled
S Amorim
S Ramadan
F L Bras
M Erlanson
C Herbaux
J-P Marolleau
E Nicolas-Virelezier
O Casasnovas
A Stamatoullas-Bastard
C Fermé
机构：
[1] Gustave Roussy,Department of Hematology
[2] EORTC Headquarters,Department of Onco
[3] CHU l’Archet,Hematology
[4] CHU Nancy-Brabois,Department of Hematology
[5] National Cancer Institute,Department of Medical Oncology
[6] Hopital Saint-Louis APHP,Department of Oncology and Hematology
[7] Université Paris Diderot,Department of Oncology
[8] Unité Hémopathies Lymphoïdes,Department of Clinical Hematology
[9] Hôpital Henri Mondor,Department of Hematology
[10] Umea Universitet,Department of Hematology
[11] Hôpital Claude Huriez,Department of Hematology
[12] Université de Lille 2,Department of Hematology
[13] CHU Amiens,undefined
[14] Université Picardie Jules Verne,undefined
[15] Leon Bérard Cancer Center,undefined
[16] CHU Dijon,undefined
[17] Centre Henri Becquerel,undefined
来源：
Bone Marrow Transplantation | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：310 / 312
页数：2
相关论文
共 50 条
  • [31] Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation
    Nazeef, Moniba
    Kahl, Brad S.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (06)
  • [32] AUTOLOGOUS STEM CELL TRANSPLANTATION FOR ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA
    Crump, M. C.
    Villa, D.
    Kuruvilla, J.
    Kukreti, V
    Franke, N.
    Tsang, R.
    Keating, A.
    HAEMATOLOGICA, 2010, 95 : S25 - S25
  • [33] Haploidentical Stem Cell Transplantation for Relapsed-Refractory Hodgkin Lymphoma: A Multicentre Analysis
    Lacerda, Marcelo
    Rodrigues, Celso Arrais
    Pereira, Andre Domingues
    Novis, Yana
    Fonseca, Marina
    Silva, Roberto
    Macedo, Maria Cristina
    Hamerschlak, Nelson
    Esteves, Iracema
    Schmidt Filho, Jayr
    Nascimento, Marina
    Rocha, Vanderson
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S319 - S319
  • [34] Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Castagna, Luca
    Carlo-Stella, Carmelo
    Mazza, Rita
    Santoro, Armando
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2015, 7
  • [35] Allogeneic stem cell transplantation for relapsed or refractory Hodgkin lymphoma: a better therapeutical perspective
    Greco, M. M.
    Carella, A. M.
    Merla, E.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S288 - S289
  • [36] The effect of rituximab in first line therapy to results of autologus haematopoietic stem cell transplantation in relapsed non-Hodgkin's lymphoma patients
    Bozdag, S. Civriz
    Topcuoglu, P.
    Bakanay, S.
    Arat, M.
    Ilhan, O.
    Beksac, M.
    Uysal, A.
    Arslan, O.
    Demirer, T.
    Gurman, G.
    Konuk, N.
    Ozcan, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S217 - S217
  • [37] THE PROGNOSTIC FACTORS EFFECTING STEM CELL TRANSPLANTATION IN CHILDREN WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA
    Atas, E.
    Kesik, V.
    Babacan, O.
    Korkmazer, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S499 - S499
  • [38] A Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma
    Perales, Miguel -Angel
    Cho, Christina
    Eaton, Anne
    Moskowitz, Alison J.
    Nguyen, Victoria
    Conzales-Dadiz, Anne Marie R.
    Devlin, Sean
    Giralt, Sergio A.
    Jakubowski, Ann A.
    Matasar, Matthew J.
    Noy, Ariela
    Portlock, Carol S.
    Straus, David J.
    Young, James W.
    Barker, Juliet N.
    Moskowitz, Craig H.
    BLOOD, 2015, 126 (23)
  • [39] Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma
    Ge, Shiliang
    Lepic, Kylie
    Bhindi, Ravi
    Berg, Tobias
    Khalaf, Dina
    Leber, Brian
    Radford, Michael
    Walker, Irwin
    Davies, Gwynivere
    Garcia-Horton, Alejandro
    CURRENT ONCOLOGY, 2025, 32 (02)
  • [40] Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis
    Broeckelmann, Paul J.
    Mueller, Horst
    Gillessen, Sarah
    Yang, Xiaoqin
    Koeppel, Larissa
    Pilz, Veronika
    Marinello, Patricia
    Kaskel, Peter
    Raut, Monika
    Fuchs, Michael
    Borchmann, Peter
    Engert, Andreas
    von Tresckow, Bastian
    LEUKEMIA, 2022, 36 (03) : 772 - 780
12345